Hall & Partners appoints Stacy Vaughn to senior US health roleHall & Partners Health has appointed Stacy Vaughn as managing partner of its US healthcare team, one of Share XHall & Partners appoints Stacy Vaughn to senior US health rolehttps://pharmaphorum.com/news/hall-partners-stacy-vaughn-beth-stagg/
Expect more M&A as Gilead names Dickinson as finance chief, say analystsGilead Sciences has named head of corporate development and strategy Andrew Dickinson as its new chief financial officer Share XExpect more M&A as Gilead names Dickinson as finance chief, say analystshttps://pharmaphorum.com/news/expect-more-ma-as-gilead-names-dickinson-as-finance-chief-say-analysts/
W2O acquires med comms agency Arcus MedicaHealthcare marketing communications agency W2O has acquired Philadelphia’s Arcus Medica to boost its scientific and med comms offering. Share XW2O acquires med comms agency Arcus Medicahttps://pharmaphorum.com/news/w2o-med-comms-agency-arcus-medica/
Guido Körfer and Marc Henschel join McCann Health GermanyPictured from left: Guido Körfer, Effie Baoutis and Marc Henschel McCann Health Germany has made two key appointments Share XGuido Körfer and Marc Henschel join McCann Health Germanyhttps://pharmaphorum.com/news/korfer-henschel-mccann-health-germany/
Alexion stalks rare disease drug from Stealth with $30m opt-in dealAlexion has taken an option on a rare disease drug from Stealth Therapeutics in late-stage development, bolstering its Share XAlexion stalks rare disease drug from Stealth with $30m opt-in dealhttps://pharmaphorum.com/news/alexion-stalks-rare-disease-drug-from-stealth-with-30m-opt-in-deal/
Football-themed film launched for World Mental Health dayA new film that tackles mental health and social media from the perspective of football influencers has been Share XFootball-themed film launched for World Mental Health dayhttps://pharmaphorum.com/news/streaming-well-healthware-football-mental-health-film/
Humira tops list of drugs with unwarranted US price hikesAbbVie’s Humira heads a list of seven medicines that collectively contributed to a $5.1 billion increase in US Share XHumira tops list of drugs with unwarranted US price hikeshttps://pharmaphorum.com/news/humira-tops-list-of-drugs-with-unwarranted-us-price-hikes/
GSK’s Walmsley backs #MeTooPay gender pay campaignGlaxoSmithKline chief executive Emma Walmsley is among more than 100 prominent businesswomen in the UK who have launched Share XGSK’s Walmsley backs #MeTooPay gender pay campaignhttps://pharmaphorum.com/news/gsks-walmsley-backs-metoopay-gender-pay-campaign/
HCA updates Pitching Code of ConductThe Healthcare Communications Association (HCA) has updated its Pitching Code of Conduct to support clients and agencies to navigate Share XHCA updates Pitching Code of Conducthttps://pharmaphorum.com/sales-marketing/hca-updates-code-of-conduct/
Lucie Harper and Kate Hawker join W2O as global practice leadersW2O has appointed healthcare communications veterans Lucie Harper and Kate Hawker as global practice leaders, based at its Share XLucie Harper and Kate Hawker join W2O as global practice leadershttps://pharmaphorum.com/news/lucie-harper-kate-hawker-w2o/
ARK launches new health comms outfitARK and Olly Childs have launched a new agency, ARK Comms, to help support the widening needs of Share XARK launches new health comms outfithttps://pharmaphorum.com/sales-marketing/ark-launches-new-health-comms-out%ef%ac%81t/
J&J settles Ohio lawsuits for $20m as opioid litigation train rumbles onJohnson & Johnson has managed to put opioid litigation in Ohio behind it with a $20 million settlement, Share XJ&J settles Ohio lawsuits for $20m as opioid litigation train rumbles onhttps://pharmaphorum.com/news/jj-settles-ohio-lawsuits-for-20m-as-opioid-litigation-train-rumbles-on/
Sobi stays on its acquisitive streak with $915m Dova dealSweden’s Sobi has added another already-marketed product to its rare disease portfolio via a $29 per share takeover Share XSobi stays on its acquisitive streak with $915m Dova dealhttps://pharmaphorum.com/news/sobi-stays-on-its-acquisitive-streak-with-915m-dova-deal/
Takeda eyes emerging markets asset sale to trim its debt; reportTakeda is said to be considering the sale of assets in emerging markets and western Europe to pay Share XTakeda eyes emerging markets asset sale to trim its debt; reporthttps://pharmaphorum.com/news/takeda-eyes-emerging-markets-asset-sale-to-trim-its-debt-report/
Envision Pharma Group relocates to larger US officesEnvision Pharma Group has opened two new East Coast offices as it seeks larger premises for its New Share XEnvision Pharma Group relocates to larger US officeshttps://pharmaphorum.com/news/envision-pharma-group-us-offices/
MHRA says Avastin can be used for AMD despite Bayer, Novartis objectionsThe UK drugs regulator has endorsed the use of Roche’s Avastin as a treatment for age-related macular degeneration, Share XMHRA says Avastin can be used for AMD despite Bayer, Novartis objectionshttps://pharmaphorum.com/news/mhra-says-avastin-can-be-used-for-amd-despite-bayer-novartis-objections/
Purdue presses ahead with bankruptcy filingAs expected, Purdue Pharma has formally filed for bankruptcy protection as it tries to resolve thousands of lawsuits Share XPurdue presses ahead with bankruptcy filinghttps://pharmaphorum.com/news/purdue-presses-ahead-with-bankruptcy-filing/
Purdue’s opioid settlement bid splits US statesPurdue Pharma’s multibillion-dollar bid to settle litigation over its involvement in the opioid crisis in the US is Share XPurdue’s opioid settlement bid splits US stateshttps://pharmaphorum.com/news/purdues-opioid-settlement-bid-splits-us-states/
